New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 25, 2014
16:09 EDTFPRXFive Prime reports Q4 EPS (43c), consensus (40c)
Reports Q4 revenue $3.78M, consensus $3.83M.
News For FPRX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 31, 2015
10:02 EDTFPRXOn The Fly: Analyst Initiation Summary
Subscribe for More Information
07:56 EDTFPRXFive Prime initiated with a Buy at Citi
Citi analyst Kennen MacKay calls Five Prime Therapeutics a promising early stage immuno-oncology company with a validated drug discovery platform. He started shares with a Buy rating and $33 price target.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use